1.
Bedima Duut. Access to medicines in low- and middle-Income countries – Is the agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) to blame?. GPJ [Internet]. 2024 Oct. 21 [cited 2026 Oct. 18];25(1):1-9. Available from: https://ghanapharmaceuticaljournal.com/ojs/index.php/gpj/article/view/1